Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;17(9):694-701.
doi: 10.1111/hiv.12379. Epub 2016 Jun 9.

Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012

C C Cheung  1 , E Ding  2 , P Sereda  2 , B Yip  2 , L Lourenco  2 , R Barrios  2   3 , Jsg Montaner  1   2 , R S Hogg  2   4 , V Lima  1   2 , D M Moore  1   2
Affiliations

Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012

C C Cheung et al. HIV Med. 2016 Oct.

Abstract

Objectives: Since 2006, the British Columbia HIV/AIDS Drug Treatment Program (DTP) has expanded enrolment and dramatically increased its number of participants. We examined the effect this expansion has had on the underlying cause of death in HIV-infected individuals.

Methods: We analysed data from participants aged 18 years and older in the DTP to measure 2-year mortality rates and causes of death from 2001 to 2012. We conducted tests of trend for all-cause and cause-specific mortality, and compared demographics and characteristics of individuals. Cox proportional hazard models were used to determine the risk of death.

Results: A total of 8185 participants received antiretroviral therapy (ART) during the study period. Mortality declined from 3.88 per 100 person-years (PY) in 2001-2002 to 2.15 per 100 PY in 2011-2012 (P = 0.02). There were significant decreases in HIV-related deaths (2.34 to 0.56 per 100 PY; P = 0.02) and deaths attributable to chronic liver disease (0.20 to 0.09 per 100 PY; P = 0.01), cardiovascular disease (0.24 to 0.05 per 100 PY; P = 0.03) and suicides (0.47 to 0 per 100 PY; P = 0.003). Multivariate models, adjusted for age, gender, history of injecting drug use, AIDS diagnoses and baseline CD4 cell counts, demonstrated that initiation of ART in all time periods after 2001-2002 was independently associated with reduced mortality (P < 0.001).

Conclusions: We observed declines in HIV-related mortality and certain non-HIV-related causes of death among participants in the BC DTP from 2001 to 2012. These findings suggest that there may be broader benefits to the increasingly liberal HIV treatment guidelines, including reductions in death caused by cardiovascular disease and chronic liver disease.

Keywords: AIDS; HIV; antiretroviral therapy; cardiovascular; liver; mortality; suicide.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
A. All-Cause and HIV-Related Mortality Rates for DTP participants receiving HAART B. Cardiovascular and Chronic Liver Disease Mortality Rates for DTP participants receiving HAART
Figure 1
Figure 1
A. All-Cause and HIV-Related Mortality Rates for DTP participants receiving HAART B. Cardiovascular and Chronic Liver Disease Mortality Rates for DTP participants receiving HAART
See this image and copyright information in PMC

References

    1. Lima VD, Lepik KJ, Zhang W, Muldoon KA, Hogg RS, Montaner JS. Regional and temporal changes in HIV-related mortality in British Columbia, 1987–2006. Can J Public Health. 2010 Sep-Oct;101(5):415–419. - PMC - PubMed
    1. Antiretroviral Therapy Cohort C. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008 Jul 26;372(9635):293–299. - PMC - PubMed
    1. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8(12):e81355. - PMC - PubMed
    1. Antiretroviral Therapy Cohort C. Mocroft A, Sterne JA, et al. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2009 Apr 15;48(8):1138–1151. - PMC - PubMed
    1. Belvedere LM, Miller CL, Hogg RS. Shifting sands: changing regional and gender-specific patterns of HIV/AIDS mortality in Canada, 1987 to 2008. Can J Public Health. 2012 May-Jun;103(3):202–206. - PMC - PubMed

Publication types

Substances